[Photo from Pexels]
The mRNA technology company Moderna (Nasdaq:MRNA) said it is planning to charge between $110 to $130 for COVID-19 vaccine doses in the U.S. once private market sales begin.Pfizer (NYSE:PFE) had previously announced that it was targeting the same range for COVID-19 vaccine doses.
Moderna CEO Stéphane Bancel said the company is now in discussions with hospitals, pharmacies and pharmacy benefit managers over plans to provide COVID-19 vaccine boosters.
Both Pfizer and Moderna plan to offer new variant-matched vaccine boosters this fall.
Falling demand, increased pricesWhile demand for COVID-19 vaccines has steeply declined over the past year, Moderna and Pfizer have made billions of dollars from the products in recent years. The two companies have jointly sold 1.2 billion doses of COVID-19 vaccines at a weighted average price of $20.69 per dose, according to KFF.
Ini…